Weight-Based Dosing of Yttrium 90 Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Titel:
Weight-Based Dosing of Yttrium 90 Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Auteur:
Wiseman, Gregory A. Conti, Peter S. Vo, Katie Schilder, Russell J. Gordon, Leo I. Emmanouilides, Christos Silverman, Dan H. Witzig, Thomas E. Darif, Mohamed Molina, Arturo